Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development (2022)
Yousef, Malaz 
; Park, Chulhun; Le, Tyson S; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar
Source: Dissolutiom Technologies. Unidade: FCF
Subjects: FÁRMACOS, SISTEMA LINFÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, v. 29, n. 2, p. 86-93, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P86. Acesso em: 06 nov. 2024.APA
Yousef, M., Park, C., Le, T. S., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, 29( 2), 86-93. doi:10.14227/DT290222P86NLM
Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 nov. 06 ] Available from: https://doi.org/10.14227/DT290222P86Vancouver
Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 nov. 06 ] Available from: https://doi.org/10.14227/DT290222P86
